Aug 2026· Frontiers in Cell and Developmental Biology· Vol 14· 0 citations· 69 references
Medicine
TL;DR
This mini-review presents the latest evidence on hypoxia-driven fibrosis through three processes: fibroblast activation and myofibroblast differentiation, macrophage polarization and paracrine effects, and endothelial-to-mesenchymal transition (EndMT).
Abstract
Cardiac fibrosis, a hallmark of adverse remodeling following myocardial infarction (MI), markedly contributes to progressive heart failure. Severe tissue hypoxia within the ischemic heart activates hypoxia-inducible factor (HIF) signaling, thereby reshaping intercellular communication among non-myocytes. This mini-review presents the latest evidence on hypoxia-driven fibrosis through three processes: (i) fibroblast activation and myofibroblast differentiation, (ii) macrophage polarization and paracrine effects, and (iii) endothelial-to-mesenchymal transition (EndMT). Recent single-cell transcriptomics studies have revealed fibroblast/immune cell heterogeneity post-injury, while metabolic shifts (e.g., glycolytic reprogramming, lactate-histone lactylation, and glutamine persistence) link hypoxia to the epigenetic regulation of fibrosis. Novel therapies, including lactate-scavenging biomaterials, eNAMPT neutralization, and timed metalloproteinase inhibition, show promise in targeting these pathways. A deeper understanding of hypoxia-mediated crosstalk may lead to the development of strategies to mitigate maladaptive fibrosis while preserving reparative scarring following MI.
The context-dependent role of sirtuin 3 (SIRT3), a mitochondrial nicotinamide adenine dinucleotide (NAD⁺)-dependent deacetylase, in linking mitochondrial homeostasis, oxidative stress, metabolic adaptation, and profibrotic signaling is discussed.
Hui Xie, Xue-Jie Zheng, Xiu-Ying Wang et al.· Molecular Biomedicine· 1 citation
Heart failure remains a leading cause of global morbidity and mortality, with cardiac fibrosis contributing to disease progression. Following myocardial injury, activated cardiac fibroblasts orchestrate adverse extracellular matrix (ECM) remodeling, which leads to tissue stiffening and compromised contractility. Despit...
Tissue fibrosis is a common pathological response to chronic injury and a major contributor to progressive organ dysfunction. In the lung, liver, heart, kidney, skin, and other organs, persistent inflammation, ischemia, toxic injury, metabolic stress, or immune dysregulation can shift repair from adaptive remodeling to...
This review synthesizes current understanding of the multilayered regulatory networks that govern VSMC-to-MLC transdifferentiation and assess therapeutic strategies that prevent or reverse this conversion, including miRNA replacement, kinase inhibition, LXR activation and autophagy induction.
Mu-Xin Zhang, Zi-Cheng Wang, Meng-Kai Lu et al.· International Journal of Mol...· 0 citations
This review moves beyond conventional pathological frameworks to examine the multi-layered synergistic actions of epigenetic regulation in cardiac fibrosis, offering a critical synthesis of these epigenetic mechanisms and pointing to plausible research directions for overcoming fibrotic progression toward heart failure...
Yan-Sheng Yao, Chong-Yu Shao, Hai-Tong Wan· Drug Design, Development and...· 0 citations